BioMark Diagnostics to open U.S. headquarters in Maryland.
News and Events – 8/13/15 TOP STORY: Emergent Receives $44M from CDC Gaithersburg’s Emergent BioSolutions will receive $44M from the CDC in support of its role in the supply of VIGIV, a therapeutic licensed by FDA for the treatment of complications due to smallpox vaccination. Emergent also announced its plans to spin-off its […]
BioMark Diagnostics Unveils U.S. Strategy
Biomark US Strategy (PDF) ———————————————
BioMark Appoints Dr. Thomas Malcolm to Lead U.S. Operations
BioMark Appoints Dr. Thomas Malcolm to Lead U.S. Operations (PDF) ———————————————
BioMark Diagnostics-Sponsored Project Receives NSERC Engage Grant
BioMark Diagnostics-Sponsored Project Receives NSERC Engage Grant (PDF) ———————————————
BioMark Diagnostics Engages LHA for Investors Relations
BioMark Engages LHA (PDF) ———————————————
New cancer strategy ‘could save thousands’ of lives
By Smitha Mundasad Health reporter, BBC News About 5,000 lives could be saved each year in England if GPs follow new guidelines on cancer diagnosis, the health watchdog NICE says. Its experts say that a new approach is necessary to tackle England’s lagging cancer survival rates. The guidelines suggest all GPs order certain tests directly, […]
Biomark Secures DTC Eligibility
Press Release – BIOMARK SECURES DTC ELIGIBILITY (PDF) ———————————————
Cancer Cases Projected to Rise 40% in 15 Years as Population Ages, Grows
About half of cancer cases can be prevented with healthy behaviours and policies WATCH CBC: http://www.cbc.ca/news/health/cancer-cases-projected-to-rise-40-in-15-years-as-population-ages-grows-1.3088717 New cancer cases are expected to increase by about 40 per cent by 2030 as the population ages and grows, the Canadian Cancer Society says. The society released its annual cancer statistics on Wednesday to provide long-term predictions on […]
BioMark Receives No Objection Letter From Health Canada
BioMark Receives No Objection Letter From Health Canada (PDF) ———————————————
BioMark and Response to Treatment
BioMark’s Principal Engineer attended the World Congress on Interventional Oncology (WCIO) May 6th – 9th in New York to discuss BioMark’s Response to Treatment program and how it would fit into the rapidly developing interventional oncology market place. BioMark’s Principal Engineer spent the month of March in Japan, Taiwan and China to explore the opportunity […]
